Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. (Q34989774)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer. |
scientific article |
Statements
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer (English)
Martin J Schlumberger
Lori J Wirth
Renato G Martins
Furio Pacini
Chantal Daumerie
Jean-Pierre Droz
Michael J Eschenberg
Yu-Nien Sun
Todd Juan
Daniel E Stepan